At start of the trading today, shares of integrated drug procurement, delivery, and healthcare platform TRxADE HEALTH Inc. (MEDS) rose 112.26% to $9.36 at the time of this writing.

TRxADE closed Wednesday’s session at $4.42, down 3.07 percent. MEDS shares traded at 0.28 million, a lower volume than the daily average of 4.26 million shares traded over the last 50 days. In the past year, MEDS share prices have fallen -26.33%, and this week they have declined -4.74%.

MEDS stock has lost -15.65% over the past three months, while it has lost -18.30% over the past six months. As of June 30, MEDS had an outstanding share count of 8.09 million while its market value was $34.74 million. As its subsidiary launches a new program, the MEDS stock has gained traction.

What was that program about?

In the United States, TRxADE is a health services IT company dedicated to optimizing the prescription journey, drug procurement, and patient engagement through technology. TRxADE is a leading drug purchasing marketplace operated by MEDS, providing price transparency to 12,100+ members nationwide. A variety of telehealth services are offered by MEDS under the Bonum Health brand.

TRxADE Bonum Health, TRxADE’s Digital Health business subsidiary, has signed a deal with Big Y Pharmacy and Wellness Centers in Massachusetts and Connecticut to distribute Telemedicine services.

• Using Bonum Health’s mobile health services and prescriber program, staffed by more than 600 board-certified medical providers, Big Y pharmacies will be able to provide their patients with affordable telemedicine.
• The partnership also offers Bonum Health prescription discount savings to Big Y patients.
• and Connecticut see increasing numbers of uninsured and underinsured consumers, and consumers are clamoring for more affordable healthcare options.
• Big Y entered into the collaboration to enhance its collaborative care network and to expand its digital healthcare offerings.
• And Bonum Health could contribute to Big Y’s diversification of digital healthcare in-store and at the community level.
• Through Bonum’s mobile application, Big Y pharmacies will be able to utilize a turnkey Telemedicine and prescription savings tool.
• Furthermore, Big Y pharmacy leadership saw an opportunity to offer their patients deeply discounted, low-cost care through Bonum.
• Additionally, Bonum Health will be expanding Big Y’s prescription discounts, using Bonum’s digital platform, for which Big Y has chosen Bonum Health.

MEDS’ other development:

MedCheks, another subsidiary of TRxADE, has recently launched the Health Passport app for iOS devices. With the MedCheks app, one can securely show medical records, such as vaccination records and test results, to gain entrance to a country, establishment, event or mode of transportation that requires proof of health. As COVID-19 subsides in certain markets, TRxADE HEALTH (MEDS) addresses the market need for cost-effective, advanced digital health applications to accelerate the reopening of the economy.